Non Alcoholic Fatty Liver Disease (nafld) - Cancer Science

Relevant Publications

The Association Between Neutrophil/High-Density Lipoprotein Cholesterol Ratio and Non-Alcoholic Fatty Liver Disease in a Healthy Population.

Issue Release: 2024

Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters.

Issue Release: 2024

Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease.

Issue Release: 2024

The role and mechanism of SUMO modification in liver disease.

Issue Release: 2024

Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway.

Issue Release: 2024

Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study.

Issue Release: 2024

Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial.

Issue Release: 2024

Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives.

Issue Release: 2024

Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects.

Issue Release: 2024

Association between the cardiometabolic index and NAFLD and fibrosis.

Issue Release: 2024

Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.

Issue Release: 2024

Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD.

Issue Release: 2024

Benzorhodol derived far-red/near-infrared fluorescent probes for selective and sensitive detection of butyrylcholinesterase activity in living cells and the non-alcoholic fatty liver of zebrafish.

Issue Release: 2024

Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy.

Issue Release: 2024

Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.

Issue Release: 2024

Bone mass, microarchitecture and turnover among young Indian women with non-alcoholic fatty liver disease.

Issue Release: 2024

Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals.

Issue Release: 2024

Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARα.

Issue Release: 2024

Correlation between controlled attenuation parameter values with SYNTAX score in patients with significant coronary artery disease.

Issue Release: 2024

The roles and potential mechanisms of plant polysaccharides in liver diseases: a review.

Issue Release: 2024

What Are the Key Government Agencies Involved?

What are the Therapeutic Strategies Targeting Ras?

How Are Small Lesions Evaluated?

What Are the Implications for Research and Development?

What is the Future of Molecular Cancer Research?

How Much Processed and Red Meat is Considered Safe?

How to Prepare for Preoperative Testing?

What Mechanisms Underlie the Role of BLM Helicase in Cancer Prevention?

What Role Do Intellectual Property Laws Play?

What Are the Challenges of Standardizing Cancer Protocols?

Partnered Content Networks

Relevant Topics